Biologics CMC-development with contracting support – Chances and challenges

Presenting on the above is Dr Hans-Martin Mueller, Associate Director, Biotech Development, Merck, Switzerland. He will be speaking at Biologic Manufacturing World Asia 2012, part of a series of conferences in the 5th Annual BioPharma Asia Convention 2012, held on 19-22 March at Marina Bay Sands, Singapore.

Dr Hans-Martin Mueller, PhD, Biotech Engineer, worked on both sides: As a contractor and as a contracting client in the Biotech industry. He began his career in a cell culture biotech startup company in Berlin. Subsequently he joined a global CRO (RCC Basel, today: Harlan Labs) where he worked as a GLP study director for big pharma and big agro clients for several years. In this role he finally became a key-account for important U.S.-based contracting clients. He then took up leading positions in Schering-Plough's Biotech Development Division in Switzerland. Thereafter he became the Global Head of the Biotech GMP Labs. He currently leads the global development teams for new entities from early clinical phases to commercialization. Dr Muelleris now part of Merck's Biologics Development Organization in the U.S.

He will be discussing more about the points below:

Biologics CMC-development with contracting support – Chances and challenges
1. Unleashing the potential of your contract network with effective relationship management
2. Effective utilization of the improved flexibility in operations with contracting support
3. Case study: Financial analysis to evaluate the need for CMC contract support in big pharma

If you are keen to find out more, join us at BioPharma Asia Convention 2012 to gain valuable insights from more than 200 experts. Contact us now for more details!